Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Chromosomal microarray and whole-exome sequence analysis in Taiwanese patients with autism spectrum disorder.

Chang YS, Lin CY, Huang HY, Chang JG, Kuo HT.

Mol Genet Genomic Med. 2019 Oct 8:e996. doi: 10.1002/mgg3.996. [Epub ahead of print]

2.

A Perspective: Active Role of Lipids in Neurotransmitter Dynamics.

Postila PA, Róg T.

Mol Neurobiol. 2019 Oct 8. doi: 10.1007/s12035-019-01775-7. [Epub ahead of print] Review.

PMID:
31595461
3.

Investigating Stochastic Differential Equations Modelling for Levodopa Infusion in Patients with Parkinson's Disease.

Saqlain M, Alam M, Rönnegård L, Westin J.

Eur J Drug Metab Pharmacokinet. 2019 Oct 8. doi: 10.1007/s13318-019-00580-w. [Epub ahead of print]

PMID:
31595429
4.

Subtyping of Parkinson's Disease - Where Are We Up To?

Qian E, Huang Y.

Aging Dis. 2019 Oct 1;10(5):1130-1139. doi: 10.14336/AD.2019.0112. eCollection 2019 Oct. Review.

5.

Hydroxyurea Facilitates Manifestation of Disease Relevant Phenotypes in Patients-Derived IPSCs-Based Modeling of Late-Onset Parkinson's Disease.

Tan Y, Ke M, Huang Z, Chong CM, Cen X, Lu JH, Yao X, Qin D, Su H.

Aging Dis. 2019 Oct 1;10(5):1037-1048. doi: 10.14336/AD.2018.1216. eCollection 2019 Oct.

6.

International meta-analysis of PTSD genome-wide association studies identifies sex- and ancestry-specific genetic risk loci.

Nievergelt CM, Maihofer AX, Klengel T, Atkinson EG, Chen CY, Choi KW, Coleman JRI, Dalvie S, Duncan LE, Gelernter J, Levey DF, Logue MW, Polimanti R, Provost AC, Ratanatharathorn A, Stein MB, Torres K, Aiello AE, Almli LM, Amstadter AB, Andersen SB, Andreassen OA, Arbisi PA, Ashley-Koch AE, Austin SB, Avdibegovic E, Babić D, Bækvad-Hansen M, Baker DG, Beckham JC, Bierut LJ, Bisson JI, Boks MP, Bolger EA, Børglum AD, Bradley B, Brashear M, Breen G, Bryant RA, Bustamante AC, Bybjerg-Grauholm J, Calabrese JR, Caldas-de-Almeida JM, Dale AM, Daly MJ, Daskalakis NP, Deckert J, Delahanty DL, Dennis MF, Disner SG, Domschke K, Dzubur-Kulenovic A, Erbes CR, Evans A, Farrer LA, Feeny NC, Flory JD, Forbes D, Franz CE, Galea S, Garrett ME, Gelaye B, Geuze E, Gillespie C, Uka AG, Gordon SD, Guffanti G, Hammamieh R, Harnal S, Hauser MA, Heath AC, Hemmings SMJ, Hougaard DM, Jakovljevic M, Jett M, Johnson EO, Jones I, Jovanovic T, Qin XJ, Junglen AG, Karstoft KI, Kaufman ML, Kessler RC, Khan A, Kimbrel NA, King AP, Koen N, Kranzler HR, Kremen WS, Lawford BR, Lebois LAM, Lewis CE, Linnstaedt SD, Lori A, Lugonja B, Luykx JJ, Lyons MJ, Maples-Keller J, Marmar C, Martin AR, Martin NG, Maurer D, Mavissakalian MR, McFarlane A, McGlinchey RE, McLaughlin KA, McLean SA, McLeay S, Mehta D, Milberg WP, Miller MW, Morey RA, Morris CP, Mors O, Mortensen PB, Neale BM, Nelson EC, Nordentoft M, Norman SB, O'Donnell M, Orcutt HK, Panizzon MS, Peters ES, Peterson AL, Peverill M, Pietrzak RH, Polusny MA, Rice JP, Ripke S, Risbrough VB, Roberts AL, Rothbaum AO, Rothbaum BO, Roy-Byrne P, Ruggiero K, Rung A, Rutten BPF, Saccone NL, Sanchez SE, Schijven D, Seedat S, Seligowski AV, Seng JS, Sheerin CM, Silove D, Smith AK, Smoller JW, Sponheim SR, Stein DJ, Stevens JS, Sumner JA, Teicher MH, Thompson WK, Trapido E, Uddin M, Ursano RJ, van den Heuvel LL, Van Hooff M, Vermetten E, Vinkers CH, Voisey J, Wang Y, Wang Z, Werge T, Williams MA, Williamson DE, Winternitz S, Wolf C, Wolf EJ, Wolff JD, Yehuda R, Young RM, Young KA, Zhao H, Zoellner LA, Liberzon I, Ressler KJ, Haas M, Koenen KC.

Nat Commun. 2019 Oct 8;10(1):4558. doi: 10.1038/s41467-019-12576-w.

7.

Simvastatin as a neuroprotective treatment for Parkinson's disease (PD STAT): protocol for a double-blind, randomised, placebo-controlled futility study.

Carroll CB, Webb D, Stevens KN, Vickery J, Eyre V, Ball S, Wyse R, Webber M, Foggo A, Zajicek J, Whone A, Creanor S.

BMJ Open. 2019 Oct 7;9(10):e029740. doi: 10.1136/bmjopen-2019-029740.

8.

Altered Visual and Proprioceptive Spatial Perception in Individuals with Parkinson's Disease.

José Luvizutto G, Souza Silva Brito T, de Moura Neto E, Aparecida Pascucci Sande de Souza L.

Percept Mot Skills. 2019 Oct 8:31512519880421. doi: 10.1177/0031512519880421. [Epub ahead of print]

PMID:
31594472
9.

Long-Term Efficacy of Safinamide on Symptoms Severity and Quality of Life in Fluctuating Parkinson's Disease Patients.

Cattaneo C, Jost WH, Bonizzoni E.

J Parkinsons Dis. 2019 Sep 25. doi: 10.3233/JPD-191765. [Epub ahead of print]

PMID:
31594253
10.

Technology-Based Objective Measures Detect Subclinical Axial Signs in Untreated, de novo Parkinson's Disease.

Di Lazzaro G, Ricci M, Al-Wardat M, Schirinzi T, Scalise S, Giannini F, Mercuri NB, Saggio G, Pisani A.

J Parkinsons Dis. 2019 Sep 28. doi: 10.3233/JPD-191758. [Epub ahead of print]

PMID:
31594252
11.

Parkinson's Disease and Fabry Disease: Clinical, Biochemical and Neuroimaging Analysis of Three Pedigrees.

Gago MF, Azevedo O, Guimarães A, Teresa Vide A, Lamas NJ, Oliveira TG, Gaspar P, Bicho E, Miltenberger-Miltenyi G, Ferreira J, Sousa N.

J Parkinsons Dis. 2019 Sep 24. doi: 10.3233/JPD-191704. [Epub ahead of print]

PMID:
31594250
12.

Gastrointestinal Immunity and Alpha-Synuclein.

Barbut D, Stolzenberg E, Zasloff M.

J Parkinsons Dis. 2019 Sep 28. doi: 10.3233/JPD-191702. [Epub ahead of print]

PMID:
31594249
13.

Comparing No-Show Rates of Neurology Outpatients with and without Parkinson's Disease: A Real-World Assessment of the Parkinsonian Personality Profile.

Bell JF, Wu Y, Sollinger AB, Muthukattil RJ, Ferrara JM.

J Parkinsons Dis. 2019 Sep 25. doi: 10.3233/JPD-191651. [Epub ahead of print]

PMID:
31594248
14.

The Transition from Standing to Walking Is Affected in People with Parkinson's Disease and Freezing of Gait.

Amundsen Huffmaster SL, Lu C, Tuite PJ, MacKinnon CD.

J Parkinsons Dis. 2019 Oct 3. doi: 10.3233/JPD-191649. [Epub ahead of print]

PMID:
31594247
15.

Introduction of Network-Based Healthcare at Kaiser Permanente.

Rompen L, de Vries NM, Munneke M, Neff C, Sachs T, Cedrone S, Cheves J, Bloem BR.

J Parkinsons Dis. 2019 Sep 25. doi: 10.3233/JPD-191620. [Epub ahead of print]

PMID:
31594246
16.

Analysis of Salivary Microbiome in Patients with Alzheimer's Disease.

Liu XX, Jiao B, Liao XX, Guo LN, Yuan ZH, Wang X, Xiao XW, Zhang XY, Tang BS, Shen L.

J Alzheimers Dis. 2019 Oct 3. doi: 10.3233/JAD-190587. [Epub ahead of print]

PMID:
31594229
17.

Combining aquatic physiotherapy with usual care physiotherapy for people with neurological conditions: A systematic review.

Moritz TA, Snowdon DA, Peiris CL.

Physiother Res Int. 2019 Oct 8:e1813. doi: 10.1002/pri.1813. [Epub ahead of print]

PMID:
31594035
18.

Identification of Biomolecular Information in Rotenone-Induced Cellular Model of Parkinson's Disease by Public Microarray Data Analysis.

Yu F, Le ZS, Chen LH, Qian H, Yu B, Chen WH.

J Comput Biol. 2019 Oct 9. doi: 10.1089/cmb.2019.0151. [Epub ahead of print]

PMID:
31593492
19.

Differential proteomic analysis of serum exosomes reveals alterations in progression of Parkinson disease.

Jiang R, Rong C, Ke R, Meng S, Yan X, Ke H, Wu S.

Medicine (Baltimore). 2019 Oct;98(41):e17478. doi: 10.1097/MD.0000000000017478.

20.

The Influence of Body Mass Index at Diagnosis on Cognitive Decline in Parkinson's Disease.

Yoo HS, Chung SJ, Lee PH, Sohn YH, Kang SY.

J Clin Neurol. 2019 Oct;15(4):517-526. doi: 10.3988/jcn.2019.15.4.517.

Supplemental Content

Loading ...
Support Center